Akeso To Boost Manufacturing Of Cancer Drug
Source:
bloombergMarkets
June 1, 2026 · 00:02
Akeso CFO Bing Wang says the Chinese biotech firm is investing “significantly” to expand manufacturing of its lung cancer drug as it anticipates growing demand in China and the US. He speaks exclusively to Bloomberg after Akeso presented positive results for the drug at the American Society of Clinical Oncology’s annual meeting. (Source: Bloomberg)
The original article opens on the publisher's website.
More from General
View topic →Australia posts second-quarter growth of 2.1%, beating expectations
cnbc
Sep 1, 2026 · 18:47
Fake 10 Downing Street listing exposes 'unfit' Booking.com, says consumer group
bbcTechnology
Sep 1, 2026 · 18:27
Massachusetts’ 80-year-old senator sees off primary challenge over his age
financialTimes
Sep 1, 2026 · 18:06
Pentagon chaos deepens after Driscoll quits in clash with Hegseth
financialTimes
Sep 1, 2026 · 17:47
Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate
nprNews
Sep 1, 2026 · 17:38
Countries mentioned